Literature DB >> 10611070

Effects of perturbation of cell polarity on molecular markers of sperm-egg binding sites on mouse eggs.

J P Evans1, J A Foster, B A McAvey, G L Gerton, G S Kopf, R M Schultz.   

Abstract

The mouse germinal vesicle (GV)-intact oocyte is a symmetric cell, with the GV centrally localized and with components of the plasma membrane and cortex symmetrically distributed around the periphery of the oocyte. During oocyte maturation, two distinct regions of the egg plasma membrane and cortex develop: the amicrovillar region overlying the meiotic spindle and the microvillar region. The development of this polarity is significant, since sperm bind to and fuse with the microvillar region. We are interested in the development of egg polarity and have characterized the localizations of several markers for egg polarity in normal metaphase II eggs and GV-intact oocytes. The asymmetric distributions of these markers (including actin, cortical granules, binding sites for the sperm proteins fertilin alpha and fertilin beta, and two different beta(1) integrin epitopes) develop during oocyte maturation in vitro, and this polarity can be perturbed by treatments that disrupt the actin microfilaments or microtubules. In addition, immunoelectron microscopy reveals that binding sites for recombinant fertilin beta are specifically localized to the microvillar region, suggesting that the binding sites for this sperm ligand are either specifically localized or activated in this region. These results indicate that structural remodeling of the mouse egg plasma membrane is accompanied by molecular remodeling, resulting in the localization or activation of specific molecules in subdomains of the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10611070     DOI: 10.1095/biolreprod62.1.76

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

1.  Prophase I mouse oocytes are deficient in the ability to respond to fertilization by decreasing membrane receptivity to sperm and establishing a membrane block to polyspermy.

Authors:  Cassie A Kryzak; Maia M Moraine; Diane D Kyle; Hyo J Lee; Caelin Cubeñas-Potts; Douglas N Robinson; Janice P Evans
Journal:  Biol Reprod       Date:  2013-08-29       Impact factor: 4.285

2.  Oocyte specific oolemmal SAS1B involved in sperm binding through intra-acrosomal SLLP1 during fertilization.

Authors:  Monika Sachdev; Arabinda Mandal; Sabine Mulders; Laura C Digilio; Subbarayalu Panneerdoss; Viswanadhapalli Suryavathi; Eusebio Pires; Kenneth L Klotz; Laura Hermens; María Belén Herrero; Charles J Flickinger; Marcel van Duin; John C Herr
Journal:  Dev Biol       Date:  2011-12-20       Impact factor: 3.582

3.  Signaling Proteins Recruited to the Sperm Binding Site: Role of β-Catenin and Rho A.

Authors:  Huizhen Wang; William H Kinsey
Journal:  Front Cell Dev Biol       Date:  2022-05-13

4.  Effect of sperm entry on blastocyst development after in vitro fertilization and intracytoplasmic sperm injection - mouse model.

Authors:  Karolina Piotrowska-Nitsche; Anthony W S Chan
Journal:  J Assist Reprod Genet       Date:  2012-12-08       Impact factor: 3.412

5.  Cortical mechanics and meiosis II completion in mammalian oocytes are mediated by myosin-II and Ezrin-Radixin-Moesin (ERM) proteins.

Authors:  Stephanie M Larson; Hyo J Lee; Pei-hsuan Hung; Lauren M Matthews; Douglas N Robinson; Janice P Evans
Journal:  Mol Biol Cell       Date:  2010-07-21       Impact factor: 4.138

6.  Reduction of mouse egg surface integrin alpha9 subunit (ITGA9) reduces the egg's ability to support sperm-egg binding and fusion.

Authors:  Ulyana Vjugina; Xiaoling Zhu; Eugene Oh; Nabal J Bracero; Janice P Evans
Journal:  Biol Reprod       Date:  2009-01-07       Impact factor: 4.285

7.  Distribution of RNA binding protein MOEP19 in the oocyte cortex and early embryo indicates pre-patterning related to blastomere polarity and trophectoderm specification.

Authors:  John C Herr; Olga Chertihin; Laura Digilio; Kula N Jha; Soumya Vemuganti; Charles J Flickinger
Journal:  Dev Biol       Date:  2007-12-04       Impact factor: 3.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.